Journal of Chemistry

Journal of Chemistry / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 7357830 | 2 pages | https://doi.org/10.1155/2019/7357830

Corrigendum to “Synthesis of Kojic Ester Derivatives as Potential Antibacterial Agent”

Received05 Aug 2019
Accepted11 Aug 2019
Published07 Oct 2019

In the article titled “Synthesis of Kojic Ester Derivatives as Potential Antibacterial Agent [1],” the sentences “Acetophenone (1.2 g, 0.1 mmol) was added to 4-carboxybenzaldehyde derivatives (0.15 g, 0.1 mmol) in methanol (50 mL). KOH (1.7 g, 0.3 mmol) in methanol was added and the mixture was stirred at room temperature for 4 h under nitrogen atmosphere” in Section 2.2 should be changed to “Acetophenone derivatives (1.2 g, 0.1 mmol) were added to 4-carboxybenzaldehyde (0.15 g, 0.1 mmol) in methanol (50 mL). KOH (1.7 g, 0.3 mmol) in methanol was added, and the mixture was stirred at room temperature for 4 h under nitrogen atmosphere.”

Additionally, there was an error in Scheme 1, where the structure of 4-carboxybenzaldehyde should be changed from “CH3” to “H.” The corrected scheme is as shown.

References

  1. C. Z. W. Sie, Z. Ngaini, N. Suhaili, and E. Madiahlagan, “Synthesis of kojic ester derivatives as potential antibacterial agent,” Journal of Chemistry, vol. 2018, Article ID 1245712, 7 pages, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Carolynne Zie Wei Sie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

263 Views | 205 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.